Adalimumab therapy used successfully for recalcitrant Hailey-Hailey disease

Ailynna Chen; Matthew DaCunha; Jessica Harms

doi:10.1016/j.jdcr.2022.09.014

Adalimumab therapy used successfully for recalcitrant Hailey-Hailey disease

JAAD Case Rep. 2022 Sep 22:29:173-176. doi: 10.1016/j.jdcr.2022.09.014. eCollection 2022 Nov.

Authors

Ailynna Chen¹, Matthew DaCunha², Jessica Harms²

Affiliations

¹ Carver College of Medicine, University of Iowa, Iowa City, Iowa.
² Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

No abstract available

Keywords: HHD; HHD, Hailey-Hailey disease; HSV, herpes simplex virus; Hailey-Hailey disease; Humira; IL, interleukin; TNF, tumor necrosis factor; TNF-α inhibitor; adalimumab; benign familial pemphigus; biologic; hereditary inflammatory dermatosis; immunotherapy.

Publication types

Case Reports